- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Results
1861
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
1861 companies
Whitehawk Therapeutics
Market Cap: US$90.1m
An oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments.
WHWK
US$1.88
7D
11.2%
1Y
3.3%
Satellos Bioscience
Market Cap: CA$112.5m
A biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia.
MSCL
CA$0.69
7D
7.8%
1Y
45.3%
InnoCan Pharma
Market Cap: CA$46.8m
A pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally.
INNO
CA$0.16
7D
-3.0%
1Y
-48.4%
Enzo Biochem
Market Cap: US$30.7m
A life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally.
ENZB
US$0.59
7D
7.4%
1Y
-43.8%
AbCellera Biologics
Market Cap: US$594.0m
Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.
ABCL
US$2.00
7D
-1.0%
1Y
-48.1%
NuCana
Market Cap: US$244.7k
A clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer.
NCNA
US$0.039
7D
-26.2%
1Y
-98.9%
Hoth Therapeutics
Market Cap: US$11.0m
A clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs.
HOTH
US$0.84
7D
-1.3%
1Y
-27.6%
Green Zebras Spolka Akcyjna
Market Cap: zł12.6m
Produces and sells herbal extracts focusing on Polish herbs and adaptogenic plants, mushrooms, fruits, and spices in Poland.
GRZ
zł9.50
7D
3.3%
1Y
n/a
BriaCell Therapeutics
Market Cap: CA$18.3m
A clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care.
BCT
CA$4.72
7D
16.5%
1Y
-84.1%
Laboratorios Farmaceuticos Rovi
Market Cap: €2.6b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€51.80
7D
-1.1%
1Y
-42.5%
Isofol Medical
Market Cap: SEK 193.7m
Operates as a clinical stage biotech company.
ISOFOL
SEK 1.20
7D
-16.3%
1Y
68.9%
Guard Therapeutics International
Market Cap: SEK 313.6m
A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.
GUARD
SEK 15.55
7D
0%
1Y
-48.2%
Kymera Therapeutics
Market Cap: US$2.0b
A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.
KYMR
US$30.17
7D
0.5%
1Y
-11.9%
Avidity Biosciences
Market Cap: US$3.7b
A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).
RNA
US$30.81
7D
6.4%
1Y
12.2%
Annexon
Market Cap: US$216.1m
A clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.
ANNX
US$2.06
7D
13.8%
1Y
-56.2%
Natera
Market Cap: US$20.6b
A diagnostics company, provides molecular testing services worldwide.
NTRA
US$152.48
7D
2.1%
1Y
41.8%
KalVista Pharmaceuticals
Market Cap: US$590.1m
A clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs.
KALV
US$11.42
7D
-2.1%
1Y
1.2%
Arbutus Biopharma
Market Cap: US$607.1m
A clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States.
ABUS
US$3.22
7D
3.2%
1Y
-1.8%
ChemoMetec
Market Cap: DKK 8.9b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 512.50
7D
2.8%
1Y
38.8%
Regulus Therapeutics
Market Cap: US$548.3m
A clinical-stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States.
RGLS
US$7.91
7D
0.8%
1Y
312.0%
Forte Biosciences
Market Cap: US$46.8m
Operates as a clinical-stage biopharmaceutical company in the United States.
FBRX
US$7.52
7D
-4.0%
1Y
-49.9%
Biohaven
Market Cap: US$1.6b
Biohaven Ltd. discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide.
BHVN
US$15.43
7D
-2.5%
1Y
-57.7%
Faes Farma
Market Cap: €1.3b
Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide.
FAE
€4.24
7D
1.4%
1Y
14.6%
Recursion Pharmaceuticals
Market Cap: US$1.7b
Operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States.
RXRX
US$4.15
7D
-2.5%
1Y
-54.1%
Kronos Bio
Market Cap: US$40.9m
A clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule therapeutics to treat cancer and other serious diseases in the United States.
KRON
US$0.69
7D
-2.4%
1Y
-29.1%
10x Genomics
Market Cap: US$1.0b
A life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.
TXG
US$8.54
7D
-7.2%
1Y
-62.8%
MiMedx Group
Market Cap: US$1.0b
Develops and distributes placental tissue allografts for various sectors of healthcare.
MDXG
US$6.72
7D
-5.2%
1Y
-13.5%
Keros Therapeutics
Market Cap: US$570.2m
A clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics for patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States.
KROS
US$14.16
7D
0.9%
1Y
-71.2%
Sareum Holdings
Market Cap: UK£20.8m
A clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases.
SAR
UK£0.15
7D
-4.6%
1Y
-53.7%
Jerusalem Pharmaceuticals
Market Cap: US$69.3m
Develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally.
JPH
US$3.85
7D
0.5%
1Y
1.0%
NLS Pharmaceutics
Market Cap: US$2.8m
A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders.
NLSP
US$1.95
7D
21.1%
1Y
-71.9%
Poltreg
Market Cap: zł167.0m
A biotechnology company, develops therapies for autoimmune diseases.
PTG
zł35.80
7D
2.3%
1Y
-26.9%
Verve Therapeutics
Market Cap: US$377.1m
A clinical-stage company, develops gene editing medicines for patients to treat cardiovascular disease in the United States.
VERV
US$4.38
7D
1.4%
1Y
-17.8%
vTv Therapeutics
Market Cap: US$63.8m
A clinical stage biopharmaceutical company, focuses on the development of orally administered treatments for metabolic and inflammatory diseases.
VTVT
US$19.45
7D
-13.2%
1Y
-32.7%
Tonix Pharmaceuticals Holding
Market Cap: US$182.3m
A biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease.
TNXP
US$26.40
7D
14.3%
1Y
-95.3%
Societe de Promotion Pharmaceutique du Maghreb
Market Cap: د.م1.2b
Societe de Promotion Pharmaceutique du Maghreb S.A.
PRO
د.م1,170.00
7D
0%
1Y
23.7%